Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

RO-5068760 exhibits potent preclinical antitumor activity in B-Raf V600E mutant tumors

Nov. 24, 2009

VER-155008 potentiates Hsp90 inhibitor-induced apoptosis in vitro

Nov. 24, 2009

Atorvastatin improves eGFR regardless of metabolic syndrome state in CHD patients

Nov. 23, 2009

ATI-2042 effective at reducing atrial fibrillation burden in phase II trial

Nov. 23, 2009

AdCD40L immunotherapy for bladder cancer deemed safe in phase I/IIa trials

Nov. 23, 2009

AT-13387 shows promising antitumor activity in mouse xenograft models

Nov. 23, 2009

Preliminary results reported from first-in-human study of FP-1039

Nov. 23, 2009

Phase II data support antitumor activity of tasisulam in platinum-resistant ovarian cancer

Nov. 23, 2009

Insight into the mechanism of action of ATI-5261, a novel synthetic peptide

Nov. 20, 2009

Chymase inhibitor improves left ventricular function after mitral regurgitation

Nov. 20, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...